Bioventus Settles for $3.6 Million over Improper Medical Necessity Claims
Bioventus, LLC, a global medical technology company, has agreed to pay over $3.6 million to resolve allegations that it submitted improperly completed certificates of medical necessity for medically unnecessary devices from 2012 through 2018.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.